212 related articles for article (PubMed ID: 6162773)
1. Occurrence and patterns of muramidase containing cells in Hodgkin's disease, non-Hodgkin's lymphomas, and reactive hyperplasia.
Ree HJ; Song JY; Leone LA; Crowley JP; Fanger H
Hum Pathol; 1981 Jan; 12(1):49-59. PubMed ID: 6162773
[TBL] [Abstract][Full Text] [Related]
2. Expression of cell adhesion molecules associated with germinal center in Hodgkin's disease: an immunohistochemical study. The germinal center related complex and histologic subtypes.
Ree HJ; Khan AA; Qureshi MN; Teplitz C
Cancer; 1994 Feb; 73(4):1257-63. PubMed ID: 7906194
[TBL] [Abstract][Full Text] [Related]
3. Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non-Hodgkin's lymphomas.
Miettinen M; Franssila KO; Saxén E
Cancer; 1983 Jun; 51(12):2293-300. PubMed ID: 6850508
[TBL] [Abstract][Full Text] [Related]
4. Macrophage-histiocyte lysozyme activity in relation to the clinical presentation of Hodgkin's disease. An immunohistochemical study.
Ree HJ; Crowley JP; Leone LA
Cancer; 1981 Apr; 47(8):1988-93. PubMed ID: 6164477
[TBL] [Abstract][Full Text] [Related]
5. A quantitative study of histiocytic reticulum cells in diffuse and follicular non-Hodgkin's lymphomas.
Crocker J; Jenkins R
J Clin Pathol; 1984 Nov; 37(11):1222-6. PubMed ID: 6389602
[TBL] [Abstract][Full Text] [Related]
6. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
Dorfman DM; Shahsafaei A
Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
[TBL] [Abstract][Full Text] [Related]
7. Ammoniacal silver staining of lymph node cells. I. its potential value for the diagnosis of Hodgkin's disease.
Rengifo E; Quintero S; Marinello Z
Neoplasma; 1983; 30(4):469-73. PubMed ID: 6193436
[TBL] [Abstract][Full Text] [Related]
8. Use of Leu M1 and antiepithelial membrane antigen monoclonal antibodies for diagnosing Hodgkin's disease.
Jack AS; Cunningham D; Soukop M; Liddle CN; Lee FD
J Clin Pathol; 1986 Mar; 39(3):267-70. PubMed ID: 3514684
[TBL] [Abstract][Full Text] [Related]
9. Leu-M1--a marker for Reed-Sternberg cells in Hodgkin's disease. An immunoperoxidase study of paraffin-embedded tissues.
Pinkus GS; Thomas P; Said JW
Am J Pathol; 1985 May; 119(2):244-52. PubMed ID: 3887932
[TBL] [Abstract][Full Text] [Related]
10. Ammoniacal silver staining of lymph node cells. II. Reactive follicular hyperplasia and its relationship with Hodgkin's disease.
Rengifo E; Quintero S; Marinello Z
Neoplasma; 1985; 32(6):741-4. PubMed ID: 2418374
[TBL] [Abstract][Full Text] [Related]
11. Follicular dendritic cells in Hodgkin's disease.
Alavaikko MJ; Hansmann ML; Nebendahl C; Parwaresch MR; Lennert K
Am J Clin Pathol; 1991 Feb; 95(2):194-200. PubMed ID: 1992609
[TBL] [Abstract][Full Text] [Related]
12. Leu M1 and S100 in Hodgkin's disease and non-Hodgkin's lymphomas.
Kornstein MJ; Bonner H; Gee B; Cohen R; Brooks JJ
Am J Clin Pathol; 1986 Apr; 85(4):433-7. PubMed ID: 3754087
[TBL] [Abstract][Full Text] [Related]
13. Lectin staining of carbohydrates of haemic cells. III. The cells of Hodgkin's disease and other lymphomas.
Collins RD; Jacobson W; Stoddart RW
Histopathology; 1982 Sep; 6(5):601-16. PubMed ID: 6183188
[TBL] [Abstract][Full Text] [Related]
14. Non-Hodgkin's lymphoma following Hodgkin's disease. A case report and immunohistochemical corroboration.
Shimizu K; Hara K; Kunii A
Am J Clin Pathol; 1986 Sep; 86(3):370-4. PubMed ID: 3529930
[TBL] [Abstract][Full Text] [Related]
15. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
[TBL] [Abstract][Full Text] [Related]
16. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies reactive in routinely processed tissue sections of malignant lymphoma, with emphasis on T-cell lymphomas.
Strickler JG; Weiss LM; Copenhaver CM; Bindl J; McDaid R; Buck D; Warnke R
Hum Pathol; 1987 Aug; 18(8):808-14. PubMed ID: 3301626
[TBL] [Abstract][Full Text] [Related]
18. Differential cell counts in the histiocytic variant of lymphocytic predominance subtype of Hodgkin's disease.
Sutherland FI; MacGillivray JB; Brown RA; Beck JS
J Clin Pathol; 1978 Dec; 31(12):1234-8. PubMed ID: 748394
[TBL] [Abstract][Full Text] [Related]
19. Hodgkin's disease, lymphocyte predominance type, nodular--a distinct entity? Unique staining profile for L&H variants of Reed-Sternberg cells defined by monoclonal antibodies to leukocyte common antigen, granulocyte-specific antigen, and B-cell-specific antigen.
Pinkus GS; Said JW
Am J Pathol; 1985 Jan; 118(1):1-6. PubMed ID: 3155594
[TBL] [Abstract][Full Text] [Related]
20. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
Davey FR; Goldberg J; Stockman J; Gottlieb AJ
Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
